10.06.2024 13:05:37 - dpa-AFX: *ASTRAZENECA SAYS TAGRISSO GRANTED PRIORITY REVIEW IN US FOR PATIENTS WITH STAGE III EGFR-MUTATED LUNG CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 139,550 27.09.24 15:44:56 -1,150 -0,82% 139,250 139,550 140,550 140,700

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH